1Lohi J;Wilson CL;Roby JD.A novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury[J],2001(13).
2Aimas RT;Quigley JP.Matrix metalloproteinase-2 is an interstitial collagenase-inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type Ⅰ collagen generating the specific 3/4-and 1/4-length fragments,1995.
3Kerkvliet EH;Docherty AJ;Beertsen W.Collagen breakdown in soft connective tissue explants is associated with the level of active gelatinase A (MMP-2) but not with collagenase[J],1999(18).
4Watanabe T;Niioka M;Hozawa S.Gene expression of interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachloride[J],2000(02).
5Herbst H;Wege T;Milani S.Tissue inhibitor of metalloproteinases-1 and-2 RNA expression in rat and human liver fibosis,1997.
7Theret N;Lehti K;Musso O.MMP-2 activation by collagen Ⅰ and concanavalin A in cultured human hepatic stellate cells[J],1999(2).
8Arthur MJP;Friedman SL;Roll FJ.Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type Ⅳ) collagen[J],1989(84).
9Arthur MJ.Fibrogenesis Ⅱ.Metalloproteinases and their inhibitors in liver fibrosis,2000.
10Goldberg GI;Marmer BL;Grant GA.Human 72-Kilodalton type Ⅳ collagenase forms a complex with a tissue inhibitor of metalloproteinases designated TIMP-2[J],1989.
6Kasahara A, Hayashi N, Mochizuki K, et al. Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. Relationship to interferon response[J]. J Hepatol,1997,26(3):574- 583.
7Murawaki Y, Kawasaki H. Pathophysiology of hepatic fibrosis [J]. Nippon Shokakibyo Gakkai Zasshi, 1999, 96 (10):1143 - 1152.
8Watanabe T, Niioka A, Ishikawa A, et al. Dynamic change of cells expressing MMP-2 mRNA and MT1-MMP mRNA in the recovery from liver fibrosis in the rat[J]. J Hepatol, 2001,35(4): 465-473.
9Xu Bo, Broome U, Uzunel M, et al. Capillarization of hepatic sinusoid by liver endothelial cell-reactive autoantibodies in patients with cirrhosis and chronic hepatitis [J]. Am J Pathol, 2003, 163(4): 1275- 1289.
10Arthur MJ. Degradation of matrix proteins in liver fibrosis [J]. PatholResPract, 1994,190(9-10):825-833.
10Kasahara A, Hayashi N, Mochizuki K, et al. Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. Relationship to interferon response[J]. J Hepatol,1997,26(3):574- 583.
